Table 3.
Clinical setting | Predictors remaining in final model | Estimate (β) | P value |
---|---|---|---|
WFNS grade 4 | |||
(lowest acceptable Hb) | Specialty (neurosurgery) | 0.37 | <0.0001 |
Years in practice | 0.01 | 0.009 | |
WFNS grade 4 | |||
(highest acceptable Hb) | Specialty (neurosurgery)b Years in practicec,d |
0.03 | 0.01 |
DCI | |||
(lowest acceptable Hb) | Years in practice | 0.02 | 0.01 |
DCI | |||
(highest acceptable Hb) | Transfusion protocol | -0.35 | 0.003 |
Years in practice | 0.02 | 0.007 | |
Transfusion protocolb Specialty (neurosurgery)b |
0.66 | 0.002 |
aMultivariable analysis was performed using generalized linear models with stepwise backward elimination of the least significant variable where P > 0.05. Initial models included country (United States vs. Canada), specialty (neurosurgery vs. critical care), multimodal monitoring (yes vs. no), use of a transfusion protocol (yes vs. no) and years in practice (continuous variable). All interactions were assessed, and those for which P < 0.05 in univariate analysis were incorporated into initial multivariable models. WFNS, World Federation of Neurological Surgeons scale; Hb, hemoglobin concentration; DCI, delayed cerebral ischemia. bNeurosurgical specialty significantly modified practices among clinicians who use a protocol (see Results section for details); cWhite's heteroscedasticity-specific standard error; dYears in practice significantly modified practices among neurosurgeons (see Results section for details).